Application of Improved Baduanjin Combined Cross-theoretical Model Based on Internet in Family Empowering Elderly PCI Cardiac Rehabilitation

Launched by THE FOURTH AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE · Apr 29, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help elderly patients with coronary heart disease recover after a procedure called PCI (Percutaneous Coronary Intervention), which is a common treatment for blocked arteries. The trial combines an exercise program called Baduanjin, which involves gentle movements, with support from family and the use of the Internet to create a better recovery plan. The goal is to empower patients and their families to actively participate in the rehabilitation process, leading to improved health outcomes.

To be eligible for this trial, participants must be aged between 60 and 75 years, have been diagnosed with coronary heart disease, and have recently undergone their first PCI with stable health afterward. Additionally, both the patients and their family members need to agree to participate in the study. If you or a loved one meet these criteria, joining the trial could provide valuable support in the recovery journey, as well as contribute to developing better rehabilitation programs for elderly patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • (1) All met the diagnostic criteria for coronary heart disease;
• • (2) PCI was performed for the first time with clear indications of PCI surgery;
• • (3) Postoperative condition was stable;
• • (4) NYHA cardiac function grade I-II;
• • (5) Age 60 \~75 years old;
• • (6) Patients and their family members gave informed consent to this study and signed informed consent, which met the ethical standards of human trials and was approved by the ethics committee of the hospital.
• Exclusion Criteria:
• • (1) Uncontrolled arrhythmias combined with hemodynamic abnormalities.
• • (2) COPD, pulmonary embolism, deep vein thrombosis, stroke and other factors affecting motor function.
• • (3) Physical disability affecting safety and full participation in the experiment.
• • (4) myocarditis, cardiomyopathy, liver and kidney insufficiency.
• • (5) Aphasia, hearing impairment and other conditions affecting normal doctor-patient communication.